Waypoint Investment Partners Refiles Interim Management Report of Fund Performance

TORONTO, Nov. 27, 2020 (GLOBE NEWSWIRE) — Waypoint Investment Partners Inc. (Waypoint) today announced the refiling of the Interim Management Report of Fund Performance (MRFP) for Waypoint All Weather Alternative Fund (the Fund). The purpose of the refiling is to:

  • correctly label the MRFP as Interim Management Report of Fund Performance which was improperly labelled as Annual Management Report of Fund Performance;
  • include the trading expense ratio for the Fund which is 1.13% and was incorrectly stated;
  • include information on the net asset value per unit at the end of the period which was omitted in the first chart under “Financial Highlights”; and
  • include information on the management expense ratio before waivers or absorptions which was omitted.

The effect on the Fund of these corrections was immaterial and no other changes were made to the MRFP. The refiled MRFP will be available on the Fund’s website at http://www.waypointinvestmentpartners.com/funds.html and on SEDAR at www.sedar.com.

Commissions, trailing commissions, management fees, and expenses all may be associated with investments in the Fund. Please read the prospectus and Fund Facts before purchasing the Fund. The Fund is not guaranteed. The net asset value of the Fund changes frequently and past performance may not be repeated.

For further information on Waypoint and the Fund, please visit www.waypointinvestmentpartners.ca.

ABOUT WAYPOINT INVESTMENT PARTNERS

Waypoint Investment Partners Inc. is a Toronto-based investment manager that services high net worth individuals, family offices, investment advisors, foundations and institutional clients. With a team of 10 experienced industry professionals, Waypoint delivers unique and proprietary products and services. Waypoint is a member of the Portfolio Management Association of Canada and is registered as an Investment Fund Manager, Portfolio Manager and Exempt Market Dealer in several Canadian provinces.

For further information, please contact Max Torokvei, Partner & Chief Executive Officer, mtorokvei@waypointinvestmentpartners.com, (416) 960-7683.



Ziopharm Comments on Institutional Shareholder Services’ Recommendation to Reject WaterMill’s Attempt to Remove Half of Ziopharm’s Board of Directors

ISS
Acknowledges Ziopharm’s
Outperformance
of
its Peer Group
During
Chairman Scott
Tarriff’s
Tenure

Court Filings R
aise Concerns About Professional Past of
WaterMill
Nominee Holger Weis

Ziopharm
Recommends Shareholders Return the GREEN Consent Revocation Card

BOSTON, Nov. 27, 2020 (GLOBE NEWSWIRE) — Ziopharm Oncology, Inc. (Nasdaq: ZIOP) (“Ziopharm” or the “Company”), today issued a response to a report issued by Institutional Shareholder Services (“ISS”) in connection with the consent solicitation initiated by WaterMill Asset Management Corp., Mr. Robert W. Postma and certain other individuals (collectively, “WaterMill”). In its report, ISS recommends that Ziopharm shareholders reject WaterMill’s attempt to remove half of the Ziopharm Board of Directors (the “Board”) and to vote against the addition of Mr. Postma to the Board. Ziopharm strongly recommends shareholders sign and return the Company’s GREEN Consent Revocation Card.

In a statement, the Company said:

“We
are gratified that ISS acknowledges
that
removing
half of Ziopharm’s Board
and replacing
them
with
WaterMill’s
full slate of proposed candidates – including Mr. Postma, himself – would not be in the best interest of shareholders or the Company
.
I
n addition, we are pleased that ISS acknowledges the track record of Ziopharm’s performance in recent years, which we believe underscores the long-term value potential in Ziopharm under the leadership of the curr
ent Board and management team.
I
mportantly, while we have a great deal of respect for ISS, the report contains
a number of
factual mistakes
. Additionally,
key information
in the public domain
relating
to
WaterMill
nominee Holger Weis
raises questions regarding his suitability as a director
.

The ISS report made clear several points relating to Ziopharm’s financial standing and performance, including by noting that “the company outperformed the median of its peer group since Tarriff assumed leadership of the board and since the company ended the Intrexon collaboration.”

However, Ziopharm’s management team and Board believe it is critical for shareholders to be aware of the following factual errors in the ISS report:

  • ISS recommends in favor of fixing the Board size at seven, but their other recommendations would result in an eight-member board.
  • ISS states that the Board “rejected” the resignations of Elan Ezickson and Dr. Scott Braunstein, but that is not correct. In fact, the Board never rejected these resignations. The Board promptly engaged two leading search firms to identify candidates in connection with the results of the 2020 annual meeting and has accepted resignations as soon as it has found suitable replacements.
  • ISS reports Elan Ezickson attended “fewer than 75 percent of meetings in 2019”, which is not accurate. Mr. Ezickson attended nearly 90% of Board and committee meetings in 2019. Mr. Ezickson attended fewer than 75% of meetings the year before that only because he was unable to participate in two special Board meetings that were called on short notice.
  • ISS’ review of Ziopharm’s material weakness is incorrect. The ISS report notes “there is nothing that prohibits the company from disclosing that remediation is underway,” when in fact Ziopharm has disclosed the remediation steps in several filings with the U.S. Securities and Exchange Commission (the “SEC”), including in its most recent Form 10-Q filed on November 5, 2020.
  • ISS also critiques the Board for the “retention of an overboarded director,” but fails to note that the issue was remedied by the director’s resignation from another board well in advance of the launch of the consent solicitation.

Additionally, ISS recommends in favor of the election of WaterMill nominee Holger Weis arguing, among other things, that he “served on a public company board”. However, the Company has not found any evidence that Mr. Weis has public company board experience, an assessment supported in WaterMill’s own disclosures. Moreover, shareholders should consider the following publicly available information relating to WaterMill nominee Holger Weis:1

  • In July 2017, a majority of shareholders executed written consents to remove Mr. Weis as President, COO, and CFO of DemeRx, Inc. (“DemeRx”). Four days later, Mr. Weis resigned from the company.
  • Less than a year after Mr. Weis’s departure, DemeRx filed for Chapter 11 bankruptcy. Importantly, in response to Mr. Weis’s creditor claim as part of the Chapter 11 bankruptcy filing, DemeRx claimed that Mr. Weis engaged in a breach of his fiduciary duties, corporate waste, misrepresentations of critical information to prospective shareholders about a clinical trial and misreporting of an FDA submission. Among other things, the DemeRx response notes the following:


“Weis made inaccurate and misleading presentations to the Board indicating that he had achieved certain performance benchmarks, when in fact he had not, resulting in the payment of cash bonuses and other excessive remuneration.”


“Weis engaged in corporate waste by awarding himself stock, a golden parachute, cash payments, and other excessive compensation based on milestones never achieved. Weis wrote


his own performa


nce evaluation. Weis painted a ‘rosy picture,’


overstated accomplishments and achievements and progress of a financing plan. Weis made unauthorized payments to himself on his last day of work, withdrawing all remaining funds from the


[


DemeRX’s


]


bank account. Weis also made certain to pay his future life insurance on his way out the door.”


“The FDA put


[


DemeRX’s


]


research project on a ‘full clinical hold’ in 2014. A potential i


nvestor,


Kieretsu


Capital LLC (‘


Kieretsu





) was interested in providing fundi


ng. Weis advised Keiretsu that ‘


Noribogaine


is now ready to


enter phase 2 clinical testing.’


But


DemeRx


was not ‘ready’ because of the FDA’s full clinical hold imposed in 2014. Weis also advised Keiretsu that


DemeRx


had ‘addressed the FDA’s concerns,’ which was materially inaccurate, as


DemeRx


had not contacted the FDA since the time the hold was imposed in 2014.”





During that time


Weis was in charge of


[


DemeRx


]


, it is estimated that Weis caused corporate waste, damages, and harm to


[


DemeRx


]


in the amount of approximately $10-12 million as the direct result of their acts and omissions, including complete and utter failure to implement adequate safeguards and controls and complete lack of oversight, that caused


[


DemeRx


]


to engage in activities and other improvident conduct beyond the scope of the PPM and that was otherwise fundamentally flawed







“Weis also ran up costs to


DemeRx


of over $868,000 in 2016 and incurring over $556,000 in debt to patent attorneys in 2016 when


D


emeRx


had already received the ‘going concern’


opinion from the outside independent auditors. Weis engaged in corporate waste


in regard to


excessive patent prosecution and foreign annuity costs, putting critical IP at risk of abandonment due to lack of funds.”

1 Objection to Claim filed by DemeRx, Inc., Case 18-14149-RAM (Document 125), filed November 5, 2018.

Information related to the WaterMill consent solicitation can be found at www.ZiopharmForward.com.

About Ziopharm Oncology, Inc.

Ziopharm is developing non-viral and cytokine-driven cell and gene therapies that weaponize the body’s immune system to treat the millions of people globally diagnosed with a solid tumor each year. With its multiplatform approach, Ziopharm is at the forefront of immuno-oncology with a goal to treat any type of solid tumor. Ziopharm’s pipeline is built for commercially scalable, cost effective T-cell receptor T-cell therapies based on its non-viral Sleeping Beauty gene transfer platform, a precisely controlled IL-12 gene therapy, and rapidly manufactured Sleeping Beauty-enabled CD19-specific CAR-T program. The Company has clinical and strategic partnerships with the National Cancer Institute, The University of Texas MD Anderson Cancer Center and others. For more information, please visit www.ziopharm.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, but not limited to, statements regarding the business strategy, plans and objectives of Ziopharm management and expectations as to and beliefs about the Consent Solicitation initiated by WaterMill. Forward-looking statements include all statements that are not historical facts, and can be identified by terms such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “hope,” “intend,” “may,” “might,” “objective,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” or similar expressions and the negatives of those terms. Any forward-looking statements are based on management’s current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. Such risks and uncertainties include, among others, the impact and results of the Consent Solicitation and other shareholder activism activities by WaterMill and/or other activist investors, the risks and uncertainties disclosed in Ziopharm’s most recent Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 as well as discussions of potential risks, uncertainties and other important factors in any subsequent filings by Ziopharm with the SEC. All information in this press release is as of the date hereof, and Ziopharm undertakes no duty to update the information, except as required by law.

Important Additional Information and Where to Find It

Ziopharm has filed a definitive consent revocation statement (the “Consent Revocation Statement”) together with a GREEN consent revocation card with the SEC in connection with the Consent Solicitation. SHAREHOLDERS ARE URGED TO READ THE CONSENT REVOCATION STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT ZIOPHARM FILES WITH THE SEC CAREFULLY IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Shareholders will be able to obtain, free of charge, copies of the Consent Revocation Statement (including the GREEN consent revocation card), any amendments or supplements thereto and any other documents that Ziopharm files with the SEC from the SEC’s website (http://www.sec.gov) or from Ziopharm’s website (www.ziopharm.com) by clicking on “Investors” and then “SEC Filings.”

Investor Relations Contacts:

Adam D. Levy, PhD, MBA
EVP, Investor Relations and Corporate Communications
(508) 552-9255
alevy@ziopharm.com

Chris Taylor
VP, Investor Relations and Corporate Communications
(617) 502-1881
ctaylor@ziopharm.com

Michael Verrechia
Morrow Sodali
(212) 300-2476
m.verrechia@morrowsodali.com

Media Relations Contacts:

Chris Kittredge, Andrew Cole and Zachary Tramonti
Sard Verbinnen & Co.
Ziopharm-SVC@sardverb.com



Correction of Options and RSUs Grant

PR Newswire

(TSXV: HAPB)

VANCOUVER, BC, Nov. 27, 2020 /PRNewswire/ – Hapbee Technologies, Inc. (TSXV: HAPB) (Hapbee or the “Company“), the Company wishes to clarify that, further to the news release dated November 13, 2020, it granted 4,266,875 (rather than 4,779,000, as previously reported) incentive stock options (the “Options“) to officers, directors and consultants of the Company pursuant to the Company’s stock option plan (the “Option Plan“). 

The Company also wishes to clarify that it granted 5,466,875 (rather than 4,910,000, as previously reported) restricted stock units (the “RSUs“) to officers, directors and key employees and consultants. 

The Company also reports that it has previously issued an additional 52,250 finder’s warrants (each a “Finder’s Warrant”) in connection with the convertible debenture financing dated June 25, 2020. Each Finder’s Warrant entitle the holder to purchase one additional subordinated voting share from the Company at an exercise price of C$0.30 per share at any time and from time to time until June 25, 2022.

About Hapbee

Hapbee is a wearable magnetic field technology company that aims to help people choose how they feel. Powered by patented ultra-low radio frequency energy (ulRFE®) technology invented and licensed by EMulate Therapeutics, Inc., Hapbee delivers low-power electromagnetic signals designed to produce sensations such as Happy, Alert, Focus, Relax, Calm and Sleepy.

You can learn more about how Hapbee works at www.hapbee.com/science.

Forward-Looking Information Disclaimer

Certain statements included in this news release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This news release contains forward looking statements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Any statements about Hapbee’s business plans or its upcoming development targets – including development of the Hapbee smartphone app, manufacturing and shipping for the Indiegogo campaign, research and development of new signals and the Company’s pursuit of a public listing – are all forward-looking information. Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, including, anticipated costs, and the ability to achieve its goals.

Factors that could cause the actual results to differ materially from those in the forward-looking statements include, failure to obtain regulatory approval, the continued availability of capital and financing, and general economic, market or business conditions, changes in legislation and regulations, increase in operating costs, equipment failures, failure of counterparties to perform their contractual obligations, litigation, the loss of key directors, employees, advisors or consultants and fees charged by service providers. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. These risks, uncertainties and assumptions include, but are not limited to, those described in Hapbee prospectus dated October 26, 2020, a copy of which is available on SEDAR at www.sedar.com, and could cause actual events or results to differ materially from those projected in any forward-looking statements. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, there be no assurance that the listing of the common shares of the Company will occur. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Readers should not place undue reliance on the Company’s forward-looking statements.

For more information, visit: www.hapbee.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cision View original content:http://www.prnewswire.com/news-releases/correction-of-options-and-rsus-grant-301181242.html

SOURCE Hapbee Technologies Inc.

VMware to Present at the UBS Global TMT Conference

VMware to Present at the UBS Global TMT Conference

PALO ALTO, Calif.–(BUSINESS WIRE)–
VMware, Inc. (NYSE: VMW), a leading innovator in enterprise software, today announced that Pat Gelsinger, VMware’s chief executive officer, will present as a keynote speaker at the UBS Global TMT Conference on Monday, December 7, 2020 at 10:00 a.m. PT/ 1:00 p.m. ET.

A live webcast will be available on VMware’s Investor Relations page at http://ir.vmware.com. The replay of the webcast will be available for two months.

About VMware

VMware software powers the world’s complex digital infrastructure. The company’s cloud, app modernization, networking, security, and digital workspace offerings help customers deliver any application on any cloud across any device. Headquartered in Palo Alto, California, VMware is committed to being a force for good, from its breakthrough technology innovations to its global impact. For more information, please visit https://www.vmware.com/company.html

Additional Information

VMware’s website is located at www.vmware.com, and its investor relations website is located at http://ir.vmware.com. VMware’s goal is to maintain the investor relations website as a portal through which investors can easily find or navigate to pertinent information about VMware, all of which is made available free of charge. The additional information includes materials that VMware files with the SEC; announcements of investor conferences and events at which its executives talk about VMware’s products, services and competitive strategies; webcasts of our quarterly earnings calls, investor conferences and events (archives of which are also available for a limited time); additional information on VMware’s financial metrics, including reconciliations of non-GAAP financial measures to the most directly comparable GAAP measures; press releases on quarterly earnings, product and service announcements, legal developments and international news; corporate governance information; and other news, blogs and announcements that VMware may post from time to time that investors may find useful or interesting.

Sandra Kerrigan

VMware Investor Relations

skerrigan@vmware.com

Michael Thacker

VMware Global Communications

mthacker@vmware.com

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Software Technology Networks Internet

MEDIA:

Logo
Logo

VMware to Present at theRaymond James Technology Investors Conference

VMware to Present at theRaymond James Technology Investors Conference

PALO ALTO, Calif.–(BUSINESS WIRE)–
VMware, Inc. (NYSE: VMW), a leading innovator in enterprise software, today announced that Sanjay Poonen, VMware’s chief operating officer, customer operations will present at the Raymond James Technology Investors Conference on Tuesday, December 8, 2020 at 12:20 p.m. PT/ 3:20 p.m. ET.

A live webcast will be available on VMware’s Investor Relations page at http://ir.vmware.com. The replay of the webcast will be available for two months.

About VMware

VMware software powers the world’s complex digital infrastructure. The company’s cloud, app modernization, networking, security, and digital workspace offerings help customers deliver any application on any cloud across any device. Headquartered in Palo Alto, California, VMware is committed to being a force for good, from its breakthrough technology innovations to its global impact. For more information, please visit https://www.vmware.com/company.html

Additional Information

VMware’s website is located at www.vmware.com, and its investor relations website is located at http://ir.vmware.com. VMware’s goal is to maintain the investor relations website as a portal through which investors can easily find or navigate to pertinent information about VMware, all of which is made available free of charge. The additional information includes materials that VMware files with the SEC; announcements of investor conferences and events at which its executives talk about VMware’s products, services and competitive strategies; webcasts of our quarterly earnings calls, investor conferences and events (archives of which are also available for a limited time); additional information on VMware’s financial metrics, including reconciliations of non-GAAP financial measures to the most directly comparable GAAP measures; press releases on quarterly earnings, product and service announcements, legal developments and international news; corporate governance information; and other news, blogs and announcements that VMware may post from time to time that investors may find useful or interesting.

Sandra Kerrigan

VMware Investor Relations

skerrigan@vmware.com

Michael Thacker

VMware Global Communications

mthacker@vmware.com

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Data Management Technology Mobile/Wireless Software Networks Internet

MEDIA:

Logo
Logo

Guess?, Inc. to Webcast Conference Call on Third Quarter Fiscal 2021 Financial Results

Guess?, Inc. to Webcast Conference Call on Third Quarter Fiscal 2021 Financial Results

LOS ANGELES–(BUSINESS WIRE)–
Guess?, Inc. (NYSE: GES) will release its financial results for the third quarter of fiscal year 2021, which ended October 31, 2020, on Wednesday, December 2, 2020. The Company will webcast a conference call at 4:45 p.m. (ET) that day to discuss the results.

A live webcast will be accessible at www.guess.com via the “Investor Relations” link. A replay of the conference will be archived on the website for 30 days.

Guess?, Inc. designs, markets, distributes and licenses a lifestyle collection of contemporary apparel, denim, handbags, watches, eyewear, footwear and other related consumer products. Guess? products are distributed through branded Guess? stores as well as better department and specialty stores around the world. At August 1, 2020, the Company directly operated 1,084 retail stores in the Americas, Europe and Asia. The Company’s partners and distributors operated 538 additional retail stores worldwide. At August 1, 2020, the Company and its partners and distributors operated in approximately 100 countries worldwide. For more information about the Company, please visit www.guess.com.

Guess?, Inc.

Fabrice Benarouche

VP, Finance and Investor Relations

(213) 765-5578

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Manufacturing Fashion Textiles Retail Specialty

MEDIA:

Boardwalktech Reports Second Quarter Fiscal 2021 Financial Results

PR Newswire

CUPERTINO, Calif., Nov. 27, 2020 /PRNewswire/ – (TSXV: BWLK) (OTCQB: BWLKF) – Boardwalktech Software Corp. (“Boardwalktech” or the “Company”), the leading digital ledger platform and enterprise software solutions company, is pleased to report its financial results for the three-month period ended September 30, 2020.  All figures are reported in U.S. dollars, unless otherwise indicated. Boardwalktech’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”).

Financial Highlights:

  • Revenues for Q2-FY21 of $1.1 million versus $1.2 million of revenue in Q2-FY20, as this decrease was due to lower professional services revenue and the impact of legacy contracts (supplemental hosting and premium services) shifting in favor of the Company’s new SaaS model, implemented in 2018. As a result of those legacy contracts being retired, Annualized Recurring Revenue for Q2-FY21 was $3.7 million, compared to $3.9 million in Q1-FY21, though the Company projects ARR to be over $5 million by Q1-FY22.
  • As evidenced of the traction of the new SaaS model, 67% of subscription revenue in Q2-FY21 came from contracts executed since 2018, up from 50% last year. Further, subscription licenses contributed 66% of total revenue in Q2-FY21 versus 53% 18 months ago (the balance of total revenue from Professional Services).
  • Despite COVID-19 headwinds, the sales pipeline grew again in Q2-FY21 and is approaching $8 million compared to $4.5 million last year.
  • Gross margin in Q2-FY21 was 86.3%, flat with Q2-FY20 but lower than the 87.0% in Q1-FY21 due to lower revenue. Cost of sales decreased in absolute dollars, even given infrastructure enhancement expenses.
  • Cash from Operating Activities for Q2-FY21 totaled $(0.1) million compared to $(0.0) million in Q2-FY20 and an 87% improvement versus $(0.9) million in Q1-FY21, reflecting continued progress towards cash-flow breakeven.
  • Adjusted EBITDA loss of $(0.4) million in Q2-FY21, a 37% improvement from a loss of $(0.6) million in Q2-FY20.
  • Non-IFRS loss for Q2-FY21 (as defined in the Non-IFRS Financial Measures section) totaled $(0.5) million, or $(0.03) per basic and diluted share, a 35% improvement versus a $(0.8) million loss in Q2-FY20, or $(0.07) per basic and diluted share.
  • Reported loss for Q2-FY21 was $(0.9) million, or loss of $(0.04) per basic and diluted share, representing an 31% improvement versus a $(1.3) million loss, or $(0.11) per basic and diluted share in Q2-FY20.

Operations highlights

  • On July 3, 2020, the Company completed a new amendment with its existing investor, SQN Venture Income Fund LP, to extend the maturity of its loan to August 2022, extended interest-only payment until August 2020.

Subsequent to the quarter:

  • On October 21, 2020, the Company announced that it had been awarded a Defense Logistics Agency (DLA) research and development project subcontract based on Boardwalk’s digital ledger solution to track and ensure food safety and prevent food contamination to U.S. military and officials stationed overseas.
  • On November 11, 2020, the Company closed a $1.3 million non-brokered private placement.
  • On November 11, 2020, the Company announced that it had completed an amendment with its existing investor, SQN Venture Income Fund LP, to: extend the maturity to January 1, 2023, extend the interest-only period of the loan by six months to February 28, 2021, and a reset of the interest rate to 14.95%.

“Boardwalktech continues to see its pipeline grow despite experiencing some extension of our sales cycle as a result of the COVID-19 pandemic,” said Andrew T. Duncan, CEO of Boardwalktech. “While total revenue may have declined slightly in the quarter, revenue from new SaaS contracts continues to grow as we see a larger proportion of our revenue base being made up of high-quality, sticky, recurring SaaS license revenue. This strategy of driving growth from new enterprise licenses is the direct result of the new business model we implemented in 2018 – to focus on establishing ourselves as a pure SaaS organization and we are pleased to see Boardwalktech gaining customer traction with this approach. The decline is directly attributable to a decrease in professional services and revenue from some legacy contracts (hosting and stand-alone services) as we continue to migrate these legacy customers towards our enterprise licensing model.”

Mr. Duncan continued, “As we continue into calendar year 2021, we anticipate a good portion of our pipeline converting into customers in the new year as they recognize the significant value that our proprietary digital ledger SaaS platform provides across the enterprise. As well, we continue to make material and permanent progress towards achieving profitability in the near future as we convert our pipeline into a long term recurring revenue base.”

About Boardwalktech Software Corp.

Boardwalktech has developed a patented Digital Ledger Technology Platform currently used by Fortune 500 companies running mission-critical applications worldwide. Boardwalktech’s digital ledger technology and its unique method of managing vast amounts of structured and unstructured data is the only platform on the market today where multiple parties can effectively work on the same data simultaneously while preserving the fidelity and provenance of the data. Boardwalktech can deliver collaborative, purpose-built enterprise information management applications on any device or user interface with full integration with enterprise systems of record in a fraction of the time it takes other non-digital ledger technology-based platforms. Boardwalktech is headquartered in Cupertino, California with offices in India and operations in North America. For more information on Boardwalktech, visit our website at www.boardwalktech.com.

Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking information and statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements.

An investment in securities of the Company is speculative and subject to several risks including, without limitation, the risks discussed under the heading “Risk Factors” in the Company’s filing statement dated May 30, 2018. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking information and forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended.

In connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cision View original content:http://www.prnewswire.com/news-releases/boardwalktech-reports-second-quarter-fiscal-2021-financial-results-301181253.html

SOURCE BoardwalkTech

Facedrive Reports Third Quarter 2020 Financial Results

Facedrive Reports Third Quarter 2020 Financial Results

TORONTO–(BUSINESS WIRE)–Facedrive Inc. (“Facedrive”) (TSXV: FD), a Canadian “people-and-planet first” tech ecosystem, today announced its financial results for its third quarter ended September 30, 2020 (“Q3 2020”). Condensed Consolidated Interim Financial Statements and accompanying Management’s Discussion and Analysis of Financial Condition and Results of Operations for Q3 2020 can be found on SEDAR at www.sedar.com.

About Facedrive

Facedrive is a multi-faceted “people-and-planet first” tech ecosystem offering socially-responsible services to local communities with a strong commitment to doing business fairly, equitably and sustainably. As part of this commitment, Facedrive’s vision is to fulfil its mandate through a number of verticals that either leverage existing technologies of the Company or project synergies with existing lines of business (the “Facedrive Verticals”). The Facedrive Verticals include its rideshare business (“Facedrive Rideshare”), sustainable e-commerce platform (“Facedrive Marketplace”), food-delivery service (“Facedrive Foods”), e-social platform (“Facedrive Social”) andits contact-tracing and sustainable health services business (“Facedrive Health”).

Facedrive Rideshare was among the first to offer a wide variety of environmentally and socially responsible solutions in the Transportation as a Service (TaaS) space, planting thousands of trees based on user consumption and offering choices between electric, hybrid and conventional vehicles (including, more recently, electric and hybrid vehicles on a subscription basis through Steer). Facedrive Marketplace offers curated merchandise created from sustainably sourced materials. Facedrive Foods offers contactless delivery of a wide variety of foods right to consumers’ doorsteps, with a focus on doing so in a socially and environmentally-conscious manner. Facedrive Social strives to keep people connected in a physically-distanced world through its HiQ and other e-socialization platforms that invite users to interact based on common interests and by offering gamification and mutual community support features. Facedrive Health strives to develop and offer innovative technological solutions to the most acute health challenges including its proprietary TraceSCAN wearable technology for contact tracing. Facedrive envisions changing the ridesharing, food delivery, e-commerce, social and health tech narratives for the better, for everyone, and is currently operational in Canada and the United States. For more about Facedrive, visit www.facedrive.com.

Facedrive Inc.

100 Consilium Pl, Unit 400, Scarborough, ON, Canada M1H 3E3

www.facedrive.com

Forward-Looking Information

Certain information in this press release contains forward-looking information. This information is based on management’s reasonable assumptions and beliefs in light of the information currently available to us and are made as of the date of this press release. Actual results and the timing of events may differ materially from those anticipated in the forward-looking information as a result of various factors. Information regarding our expectations of future results, performance, achievements, prospects or opportunities or the markets in which we operate is forward-looking information. Statements containing forward-looking information are not facts but instead represent management’s expectations, estimates and projections regarding future events or circumstances. Many factors could cause our actual results, level of activity, performance or achievements or future events or developments to differ materially from those expressed or implied by the forward-looking statements.

See “Forward-Looking Information” and “Risk Factors” in Facedrive’s Filing Statement dated August 28, 2019 for a discussion of the uncertainties, risks and assumptions associated with these statements. Readers are urged to consider the uncertainties, risks and assumptions carefully in evaluating the forward-looking information and are cautioned not to place undue reliance on such information. We have no intention and undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Media Contact: Sana Srithas | sana@facedrive.com

Sayan Navaratnam

Chief Executive Officer and Director

Tel: 1-888-300-2228

 

 

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Philanthropy Retail Other Consumer Consumer Environment Other Philanthropy Food/Beverage

MEDIA:

Logo
Logo

Major Precious Metals Completes Skaergaard Acquisition

VANCOUVER, British Columbia, Nov. 27, 2020 (GLOBE NEWSWIRE) — Major Precious Metals Corp. (“Major Precious Metals” or the “Company”) (CSE:SIZE | OTC:SIZYF | FRANKFURT:3EZ) is pleased to announce that it has completed the acquisition of a one-hundred-percent interest in the Skaergaard Project (“Skaergaard”) located on the east coast of Greenland (the “Acquisition”).

The Acquisition was completed pursuant to the terms of a definitive purchase agreement entered into with Platina Resources Ltd. (the “Vendor” or “Platina”). In consideration for the Acquisition, the Company was required to complete a one-time cash payment of $500,000 (the “Consideration Payment”), and issue 55,000,000 common shares (the “Consideration Shares”), to the Vendor. The Company previously deposited the Consideration Payment, and the Consideration Shares, in escrow pending receipt of approval for the fundamental change from the Canadian Securities Exchange (the “Exchange”) and the shareholders of the Company. Such approval has now been received, and the Consideration Payment and the Consideration Shares have been released to the Vendor. In addition, the two mineral exploration licences (MEL) that comprise the Skaergaard Project (MEL 2007/01 and 2012/25) have been transferred to Major Precious Metals.

The Consideration Shares are subject to a twenty-four-month time release pooling arrangement, during which time they may not be transferred, assigned, pledged or otherwise traded. The Consideration Shares will be released from the pooling arrangement in four equal tranches, with the first release after six months, and each subsequent release occurring every six months thereafter. The Consideration Shares are subject to accelerated release in connection with share price performance, changes in corporate structure or the distribution of the Consideration Shares to the shareholders of the Vendor. In addition to the pooling arrangement imposed by the terms of the Acquisition, the Consideration Shares are subject to a statutory hold period in accordance with applicable securities laws until February 28, 2021.

The Company is at arm’s-length from the Vendor. Pursuant to the terms of the Acquisition, the Vendor is entitled to nominate one member of the board of directors of the Company. The Company anticipates that the Vendor will exercise this right and propose a nominee at a later date. In connection with completion of the Acquisition, the Company has issued 3,850,000 common shares (the “Finder’s Fee Shares”) to an arm’s-length third party that assisted in facilitating the Acquisition. The Finder’s Fee Shares are subject to four-month-and-one-day statutory hold period until March 17, 2020, in accordance with applicable securities laws.

For further information regarding the Acquisition, and the Skaergaard Project, readers are encouraged to review the Exchange Form 2A Listing Statement prepared by the Company in support of the Acquisition and fundamental change, a copy of which is available under the profile for the Company on SEDAR (www.sedar.com).

Early Warning Report

In connection with the Acquisition and following the release of the Consideration Shares from escrow, Platina has acquired ownership and control of 55,000,000 common shares of the Company representing approximately 31.1% of the issued and outstanding common shares of the Company. Prior to completion of the Acquisition, Platina did not hold any securities of the Company.

Platina has acquired the common shares of the Company for investment purposes, and in consideration for the Acquisition. Platina may, from time to time, acquire or dispose of additional securities of the Company in the market, privately or otherwise. A copy of the early earning report filed by Platina in connection with the Acquisition is available under the profile for the Company on SEDAR.

Skaergaard
MRE
Update
and Palladium Outlook

RPA Inc. (“RPA”) continues to work on the Mineral Resource Estimate (MRE) for Skaergaard and will also be incorporating the results from a core resampling program, with MRE results expected by the end of this year. As previously disclosed by the Company, the Skaergaard Intrusion contains a significant deposit of gold and platinum group metals (PGMs) dominated by palladium, importantly, outside of the major PGM producing areas of South Africa and Russia. The Company and its consultants will be examining the impact of recent increases in palladium and gold prices on the key assumptions and parameters for the MRE.

Palladium, which reached a high of US$2,875.50 per ounce in February 2020 and recently up to US$2,500 per ounce, has been affected by significant supply shortages according to metal traders and analysts such as S&P Global (source: November 4, 2020 Consensus Price Forecast – S&P Global – Market Intelligence). Palladium is an important critical metal used in automobile catalytic converters (internal combustion engine or “ICE”) to reduce harmful emissions and is the key for countries to meet stricter global emissions standards on ICE vehicles. According to S&P Global, the consensus view is that the prospect of a slowdown in the European Union auto sales due to COVID-19 lockdown restrictions has weighed price forecasts for platinum, with a downgrade of 0.2% for 2020 and 2% average reductions for 2021-24. In contrast, consensus prices for palladium are bullish, reflecting a sharp rebound in Chinese ICE vehicle sales into 2021 and analyst forecasts playing catch up with the strong price rally seen in the second half of 2020. Palladium price forecasts have therefore been upgraded 1.8% for 2020 and 3%-9% for 2021-24 according to S&P Global.

Based on the recent price forecast for palladium and the continued strength in gold prices, the Company expects to include other areas of mineralization previously not considered within the Skaergaard intrusion and to improve the palladium and gold cut-off grades compared to historical estimates.

Qualified Person Statement

All scientific and technical information contained in this news release was prepared and approved by Paul Ténière, P.Geo., President and CEO of the Company, who is a Qualified Person as defined in NI 43-101.

On behalf of the Board of Directors

MAJOR PRECIOUS METALS CORP.

Paul Ténière, M.Sc., P.Geo.
President and Chief Executive Officer
Suite 810 – 789 West Pender Street
Vancouver, BC V6C 1H2
Ph: (604) 687-2038

About Major Precious Metals Corp.

Major Precious Metals is a Canadian junior mining and exploration company based in Vancouver, BC that owns a diversified portfolio of exploration properties within some of the most promising precious and base metal deposits worldwide. Major Precious Metals is also engaged in the business of acquiring and exploring precious metal projects near or adjacent to existing mining operations controlled by well-established mining companies.

Major Precious Metals is listed on the Canadian Securities Exchange (“CSE”) and its common shares trade under the ticker symbol “SIZE.” Additional information relating to Major Precious Metals is available at www.majorprecious.com and SEDAR at www.sedar.com.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release.

Forward-looking Information Statement

This news release may contain certain “forward-looking statements” and “forward-looking information” within the meaning of applicable Canadian and United States securities laws. When used in this news release, the words “anticipate”, “believe”, “estimate”, “expect”, “target, “plan”, “forecast”, “may”, “schedule” and other similar words or expressions identify forward-looking statements or information. These forward-looking statements or information may relate to the
development of a mineral resource estimate for the
Skaergaard
Project
, and other factors or information. Such statements represent the Company’s current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and
unknown,
could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affections such statements and information other than as required by applicable laws, rules and regulations.



UPCOMING DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Precigen, Inc. f/k/a Intrexon– PGEN, XON

NEW YORK, Nov. 27, 2020 (GLOBE NEWSWIRE) — Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Precigen, Inc. f/k/a (NASDAQ: PGEN, XON) from May 10, 2017  through September 25, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Precigen, Inc. f/k/a Intrexon Corporation investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that adverse facts about its business. As such, the Company’s financial statements for the quarter ended March 31, 2018 were false and could not be relied upon; the Company had material weaknesses in its internal controls over financial reporting; the Company was under investigation by the SEC since October 2018; and as a result of the foregoing, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you wish to serve as lead plaintiff, you must move the Court no later than December 4, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

No class has been certified. Until a class is certified, you are not represented by counsel unless you hire one. You may hire counsel of your choice. You may also do nothing at this time and be an absent member of the class. Your ability to share in any future recovery is not dependent upon being a lead plaintiff.

Pawar Law Group represents investors from around the world. Attorney advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
——————————-

Contact:  
Vik Pawar, Esq.  
Pawar Law Group  
20 Vesey Street, Suite 1410  
New York, NY 10007  
Tel: (917) 261-2277  
Fax: (212) 571-0938  
info@pawarlawgroup.com